This issue of the Journal is primarily focused on new advances in the diagnosis and treatment of opioid use disorder. The issue begins with an overview by Drs. Cecilia Bergeria and Eric Strain from Johns Hopkins University (1) that discusses the prevalence of opiate use disorder and associated lethal overdoses as well as current pharmacologic and nonpharmacologic treatment approaches. Elsewhere in the issue, making the diagnosis of prescription-related opiate use disorder (POUD) can be challenging and in this regard a paper explores the impacts of modifying current criteria for POUD on prevalence rates. Another paper assesses the efficacy of buprenorphine/naloxone, primarily taken at home, for treating POUD. Also related to treatment, another paper characterizes the effects of COVID-19 telehealth policy changes related to buprenorphine treatment on VA patients with opiate use disorder. We also present papers in this issue that address the prevalence of cannabis use disorder in the VA population and the possibility of using a mindfulness-based intervention as a nonpharmacologic treatment for pain. To read the full article, choose Open Athens “Institutional Login” and search for “Midlands Partnership”.
How do you use information for your work and CPD? What do you think of MPFT library services? Tell us here and you could win £25 vouchers: https://www.surveymonkey.co.uk/r/B2JVNPR
We've added 10 new Be Aware updates following your suggestions:
Musculoskeletal ; Osteoporosis ; Nutrition and obesity ; Falls ; HR ; Research Methods ; Information Governance ; Bladder, bowel and pelvic healthcare ; Rheumatology ; Medicines and healthcare products regulatory agency (circulated email)
We'd like to hear your suggestions for new book alert topics. Simply reply to this email with 'Book Alert Topic' and your suggestions. You can also view and sign-up to our current new book alerts here: http://library.sssft.nhs.uk/librarykeepuptodate